# Pharmacyclics LLC, South San Francisco, CA – FDA Inspections

Source: https://www.keypedia.com/companies/pharmacyclics-llc/ac914c47-3023-4974-a8f2-6241d0db58b8

> Inspection records and compliance data for Pharmacyclics LLC in South San Francisco, California. 5 FDA inspections on record, 1 Form 483, last inspected April 27, 2022.

---

## Details

- Name: Pharmacyclics LLC
- FEI Number: 1000522932
- Address Line 1: 1000 Gateway Blvd
- City: South San Francisco
- State: California
- Zip Code: 94080
- Country Name: United States
- Address: 1000 Gateway Blvd, South San Francisco, California 94080, United States
- Country: United States

## Related Documents

- [483 - Pharmacyclics LLC - 2022-04-27](https://www.keypedia.com/records/483/pharmacyclics-llc/13d32dfd-1ab9-4ca3-89ec-acf12f21e6aa) — source: FDA, date: April 27, 2022
- [FDA Inspection 1169285 - Pharmacyclics LLC - 2022-04-27](https://www.keypedia.com/records/fda_inspections/pharmacyclics-llc/bb0d83c2-65e5-4cda-b89e-e5cac46dd280) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 27, 2022
- [FDA Inspection 1010437 - Pharmacyclics LLC - 2017-03-24](https://www.keypedia.com/records/fda_inspections/pharmacyclics-llc/0822a395-dbb0-412c-b165-adb64ce8f1e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2017
- FDA Inspection 909656 - Pharmacyclics LLC - 2014-12-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 5, 2014
- FDA Inspection 909656 - Pharmacyclics LLC - 2014-12-05 — classification: No Action Indicated (NAI), source: FDA, date: December 5, 2014
- FDA Inspection 853597 - Pharmacyclics LLC - 2013-10-11 — classification: No Action Indicated (NAI), source: FDA, date: October 11, 2013
- [FDA Inspection 849761 - Pharmacyclics LLC - 2013-09-11](https://www.keypedia.com/records/fda_inspections/pharmacyclics-llc/45baa1bd-ba2d-4ace-8450-c3f745d21f4b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2013

## Related Companies

- [Janssen Pharmaceuticals, dba Actelion Pharmaceutical](https://www.keypedia.com/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d)
- [Rajinder S. Shiwach, M.D.](https://www.keypedia.com/companies/rajinder-s-shiwach-md/1c35f8c6-ef47-4802-b976-011300458fec)
- [SC Johnson Professional USA, Inc.](https://www.keypedia.com/companies/sc-johnson-professional-usa-inc/e9b50d00-3095-4f01-9e05-4f21adc9812a)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)
- [Imaging Endpoints II, LLC.](https://www.keypedia.com/companies/imaging-endpoints-ii-llc/fcd4f5a9-856c-404f-b6f1-0fa2cb3c88f7)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Dakhil, Dr Shaker](https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [Upsher-Smith Laboratories, LLC](https://www.keypedia.com/companies/upsher-smith-laboratories-llc/abe71588-9a29-43ec-9663-eabd373c78c5)
- [Ascend Laboratories, LLC](https://www.keypedia.com/companies/ascend-laboratories-llc/13da97c0-bcd0-4d01-9c02-8a46b089cfc5)

## Related Officers

- [investigator](https://www.keypedia.com/people/dustin-r-abaonza/0a9994bd-d6ab-47cc-8f1b-5bf4d10bd852)
